Director, Trade and Distribution
Quick Summary
The Director, Trade will lead the development and execution of REGENXBIO’s U.S. trade and distribution strategy supporting its rare disease gene therapy portfolio. This role will lead the selection,
The Director, Trade will lead the development and execution of REGENXBIO’s U.S. trade and distribution strategy supporting its rare disease gene therapy portfolio. This role will lead the selection, contracting, implementation, and ongoing management of specialty distributors, specialty pharmacies, third-party logistics providers, and assist with management of HUB services and other patient-support partners. The position will establish the operational infrastructure required to support treatment centers, facilitate patient access, and ensure launch readiness. The Trade role will establish a plan that supports the overall corporate goals and market access strategies for REGENXBIO.
We are looking for someone who thrives in a collaborative, patient-focused environment with the following skills:
At REGENXBIO, we're committed to fostering an environment where people can do meaningful work, grow professionally, and make an impact. Our core values - trust, accountability, perseverance, and innovation - drive everything we do.
We offer a comprehensive and competitive benefit and compensation package that includes market-competitive salaries, an annual bonus program, education assistance, paid caregiver leave, a retirement plan with employer match, stock options at all levels, summer hours, and more. The estimated compensation range for this role is $190,000 – $270,000 annually. The actual salary offered to the final candidate depends on factors such as relevant work experience, skills, education, and years of experience.
Location & Eligibility
About this job
- Pay per year
- $190,000–$270,000 a year
- 241% above the $67,500 median for Other jobs on Jobera (151,246 salaries).
- Posted
- 5 days ago
Listing Details
- Posted
- November 16, 2026
- First seen
- November 16, 2026
- Last seen
- November 21, 2026
Posting Health
- Days active
- 4
- Repost count
- 0
- Trust Level
- 87%
- Scored at
- November 21, 2026
Signal breakdown
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy, utilizing its proprietary NAV® Technology Platform to develop a pipeline of AAV therapeutics for retinal, metabolic, and neurodegenerative diseases.
View company profile4 other jobs at
View all →Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.
